Evotec Releases Corporate Update
18 mars 2013 02h44 HE
|
Evotec AG
HAMBURG, Germany, March 18, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that Dr Werner Lanthaler, Chief Executive Officer of Evotec, will resume his role as Chief...
Evotec Achieves Milestone in Drug Discovery Collaboration With Ono Pharmaceutical Co., Ltd.
11 janv. 2013 01h46 HE
|
Evotec AG
Evotec Receives a Milestone Payment From Ono for the Progression of a Compound Into Pre-Clinical Development
HAMBURG, Germany, Jan. 11, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT)...
Evotec and Yale University Form Open Innovation Alliance
09 janv. 2013 01h42 HE
|
Evotec AG
HAMBURG, Germany, Jan. 9, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that it has entered into a strategic partnership with Yale University.
Under the agreement,...
Evotec to Present at J.P. Morgan Healthcare Conference
07 janv. 2013 09h14 HE
|
Evotec AG
HAMBURG, Germany, Jan. 7, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) announced today that its management will present at the J.P. Morgan Healthcare Conference in San Francisco,...
Evotec Expands Collaboration With MedImmune, Receives Milestone Payment
07 janv. 2013 01h36 HE
|
Evotec AG
HAMBURG, Germany, Jan. 7, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that it has expanded the scope of its collaboration with MedImmune, the global biologics arm of...
Evotec Acquires Cell Culture Service GmbH
03 janv. 2013 01h43 HE
|
Evotec AG
STRENGTHENS CELL-BASED SCREENING AND REAGENT PLATFORM AT EVOTEC'S HAMBURG SITE
ADDS HIGH-MARGIN BUSINESS WITH AN EXPECTED REVENUE OF MORE THAN €1.0 M IN 2013
INITIAL...
Evotec and Apeiron Biologics Announce Collaboration on Cancer Immunotherapy
02 janv. 2013 01h46 HE
|
Evotec AG
HAMBURG, Germany, Jan. 2, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that Evotec and Apeiron Biologics have entered into a research collaboration with the objective of...
Evotec Announces NMDA Antagonist License Agreement
17 déc. 2012 03h37 HE
|
Evotec AG
HAMBURG, Germany, Dec. 17, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that it has entered into a license agreement with Janssen Pharmaceuticals, Inc. ("Janssen")...
Evotec Enters Biology Collaboration With Probiodrug
28 nov. 2012 01h43 HE
|
Evotec AG
HAMBURG, Germany, Nov. 28, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) announced today that it has entered into a collaboration with Probiodrug AG, a privately owned biopharmaceutical...
Evotec Receives CIR (French Research Tax Credit) Accreditation
23 nov. 2012 01h50 HE
|
Evotec AG
HAMBURG, Germany, Nov. 23, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that it has received CIR accreditation for a three-year period from the French Ministry of Higher...